Jean C. Emond, MD

Jean C. Emond, MD Specialties: Hepatobiliary Surgery, Transplant Surgery, Cancer Care, General Surgery, Pediatric Surgery

Jean C. Emond, MD
Specialties: Hepatobiliary Surgery, Transplant Surgery, Cancer Care, General Surgery, Pediatric Surgery
phone icon
checkmark iconAccepting new patients
"
One of America's Top Doctors - Castle Connolly Top Doctors
Rated one of New York Magazine's Best Doctors

Address

1980 Crompond Rd
Cortlandt Manor, NY 10567
US
Other Locations

Additional Locations for Jean C. Emond, MD

  • phone icon
    622 West 168th Street
    Floor 14
    New York, NY 10032
    US

insurance iconinsurance icon
Insurances Accepted

Please contact the doctor's office to verify that your insurance is accepted.

  • AETNA
  • Affinity Health Plan
  • AgeWell
  • Amida Care
  • Capital District Physician Health Plan
  • CIGNA
  • Elderplan
  • Emblem/GHI
  • Empire Blue Cross/Blue Shield
  • Fidelis Care
  • Health First
  • Health Insurance Plan of NY (HIP)
  • Health Plus - Amerigroup
  • Local 1199
  • Magnacare (National)
  • Medicare
  • Multiplan
  • MVP Health Care
  • Oxford Health Plans
  • United Health Care
  • VNSNY CHOICE SelectHealth
  • WellCare

about iconabout icon
About Jean C. Emond, MD

Dr. Emond is the Vice Chairman of Surgery and Chief of the Transplantation Services at Columbia University. He has over 30 years of experience performing liver transplantation and complex liver and biliary surgery in children and adults, including the first living donor liver transplantation (LDLT) in the United States. Dr. Emond has published extensively in this field and was the co-chair of the NIH A2ALL program for 13 years. In collaboration with the department of Medicine at Columbia, Dr. Emond recruited the leadership of the Columbia Center for Translational immunology that created the foundation for translational and clinical research in transplantation tolerance. This will lead the...
Dr. Emond is the Vice Chairman of Surgery and Chief of the Transplantation Services at Columbia University. He has over 30 years of experience performing liver transplantation and complex liver and biliary surgery in children and adults, including the first living donor liver transplantation (LDLT) in the United States. Dr. Emond has published extensively in this field and was the co-chair of the NIH A2ALL program for 13 years. In collaboration with the department of Medicine at Columbia, Dr. Emond recruited the leadership of the Columbia Center for Translational immunology that created the foundation for translational and clinical research in transplantation tolerance. This will lead the way to inducing transplant tolerance in liver patients with the mixed chimerism strategy. As Director of Transplantation at the Columbia University Medical Center Dr. Emond’s activities foster clinical excellence and research across all 11 of the solid organ transplant programs at the Medical Center. In recognition of his national and international leadership in transplantation, Dr. Emond is the past president of the American Society of Transplant Surgeons, the pre-eminent association of a transplant surgery. Contribution to Science Living donor liver transplantation Dr. Emond has spent a substantial portion of his career developing living donor liver transplantation and studying the safety of the procedure in both the donor and recipient. He participated in the first living donor liver transplant in the United States and focused on refining the techniques of performing living donor liver transplants and split liver transplants. He was the national co-chair of the NIH-sponsored Adult-to-Adult Living Donor Liver Transplantation (A2ALL) consortium from 2002 to 2015 to study the safety and outcomes of living donor liver transplants. Hepatic resection/ischemia Dr. Emond developed techniques for surgical resection of liver tumors and studied the effect of ischemia during resection on postoperative liver function. These studies include the outcomes of the extent of hepatectomy, the biochemical response to major hepatectomy and ischemia-reperfusion injury of the liver in rodent models. He has studied the clinical safety of inducing total vascular exclusion to provide a bloodless field during the liver transection. This has applications in both liver cancer and living donor hepatectomies. Hepatocellular carcinoma treatment Dr. Emond has studied many aspects of managing patients with hepatocellular carcinoma. These studies have included characterizing the risk factors for recurrence of disease following transplantation due to comorbidities and tumor characteristics. The research team has also studied the optimal method of preventing tumor growth in patients with HCC on the liver transplant wait list in addition to optimal strategies of liver allocation to optimize outcomes following liver transplantation. These studies have contributed to proposed changes in UNOS exception point allocation for liver transplant candidates with HCC. Pediatric liver transplantation Dr. Emond helped develop the field of pediatric liver transplantation. Contributions to this field include: the use of living donors for pediatric patients; use of auxiliary liver transplants for metabolic diseases; use of partial liver grafts for pediatric patients; and technical modifications that improved outcomes for this patient population.

Hospital Affiliations

  • NewYork-Presbyterian / Columbia University Irving Medical Center
  • NewYork-Presbyterian / Weill Cornell Medical Center
  • NewYork-Presbyterian Hudson Valley Hospital
  • NewYork-Presbyterian Lawrence Hospital

Expertise

  • Biliary Surgery

  • Hepatobiliary Surgery

  • Immuno Suppression

  • Liver Cancer

  • Liver Resection Surgery

  • Liver Transplant, Pediatric

  • Liver Transplantation

  • Living Donor Transplantation

  • Management of Liver Transplant Complication

  • Portal Hypertension Surgery

  • Transplant Surgery, Pediatric

  • Vascular Reconstruction

Education

  • Fellowship: University of Chicago, Liver Transplantation

Board Certifications

  • Surgery

Languages Spoken

  • French
  • Spanish

awards iconawards icon
Awards

  • Americas Top Doctors for Cancer, 2005~2020
  • Americas Top Doctors, 2001~2020
  • Andrew Mellon Young Faculty Member
  • Doctor of the Year, Latino Organization for liver awareness, 2000
  • Eleanor B. Pillsbury Fellowship
  • Ellis Island Medal of Honor, 2000
  • French Government Post-Graduate Scholarship
  • Fulbright Travel Grant for International Study
  • Honorary Faculty Member AOA
  • Named in The Best Doctors in America Woodward/White, Inc.
  • New York Magazine Top Doctors, 2002~2020
  • PEW Scholars Program-University of Chicago nominee
  • Physician Honoree, TRIO Manhattan, 2005
  • Physician of the Year, American Liver Foundation, 2013
  • Ray and Joan Kroc Traveling Scholarship
  • Top Doctors New York Metro Area, 2002~2020